AIM ImmunoTech

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell AIM ImmunoTech and other ETFs, options, and stocks.

About AIM

AIM ImmunoTech, Inc. is a immuno-pharma company, which focuses on the research and development of therapeutics to treat multiple types of cancers, various viruses and immune-deficiency disorders. Its products include Alferon N Injection and Ampligen. 

CEO
Thomas Kenwood Equels
CEOThomas Kenwood Equels
Employees
19
Employees19
Headquarters
Ocala, Florida
HeadquartersOcala, Florida
Founded
1966
Founded1966
Employees
19
Employees19

AIM Key Statistics

Market cap
3.93M
Market cap3.93M
Price-Earnings ratio
-0.04
Price-Earnings ratio-0.04
Dividend yield
Dividend yield
Average volume
428.26K
Average volume428.26K
High today
$0.5064
High today$0.5064
Low today
$0.4758
Low today$0.4758
Open price
$0.4995
Open price$0.4995
Volume
324.79K
Volume324.79K
52 Week high
$20.35
52 Week high$20.35
52 Week low
$0.475
52 Week low$0.475

Stock Snapshot

With a market cap of 3.93M, AIM ImmunoTech(AIM) trades at $0.48. The stock has a price-to-earnings ratio of -0.04.

During the trading session on 2026-04-22, AIM ImmunoTech(AIM) shares reached a daily high of $0.51 and a low of $0.48. At a current price of $0.48, the stock is +1.3% higher than the low and still -4.8% under the high.

Trading activity shows a volume of 324.79K, compared to an average daily volume of 428.26K.

Over the past 52 weeks, AIM ImmunoTech(AIM) stock has traded between a high of $20.35 and a low of $0.48.

Over the past 52 weeks, AIM ImmunoTech(AIM) stock has traded between a high of $20.35 and a low of $0.48.

AIM News

TipRanks 6d
AIM ImmunoTech highlights accelerating momentum in pancreatic cancer program

AIM ImmunoTech (AIM) highlighted accelerating momentum in its pancreatic cancer program, underscored by Phase 3 trial planning underway, Phase 2 clinical signal...

People also own

Based on the portfolios of people who own AIM. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.